We are Healthcare Mittelhessen
Education, research, economy: The intensive networking in the health sector and medicine
makes the location Central Hessen special throughout Germany.
Corona News
Innovations versus Corona
The strength of the healthcare hotspot in the heart of Germany is particularly evident in the corona crisis: many strands of national and global events are converging in Central Hessen these days. We provide an overview of the most exciting projects.
> Learn more
The Gießen-based company Munditia Technologies GmbH has developed an antiviral and antibacterial surface coating with long-term effect that kills SARS-CoV-2 viruses. This development could be a worldwide breakthrough for hygiene measures against the corona pandemic.
Read more
Respirators are now a scarce commodity. Scientists from the Technical University of Central Hesse (THM) and the University Hospital Giessen/Marburg (UKGM) want to change this with a simple and cost-effective solution.
Read more
Latest Stories
Marburg-based pharmaceutical company CSL Behring is conducting intensive research on a suitable active substance against Covid-19 with the use of donated blood plasma. A globally active "Plasma Alliance" established for this purpose supports the company's goals.
Read more
The fight against SARS-CoV-2 can be conducted on different levels. Alcedis is currently participating in three clinical studies on coronavirus infection.
Read more
Good medicine needs secure financing: The medService of Volksbank Mittelhessen offers doctors, pharmacies and clinics tailor-made financing for investments, devices and office equipment.
Read more
Giessen dermatologist and professor Dr. Peter Mayser has succeeded in developing a natural anti-dandruff agent in collaboration with Symrise AG, which is being marketed under the name Crinipan® PMC green.
Read more
Courses of study with a focus on healthcare are growing enormously at the Technical University of Middle Hessen (THM) in Giessen. University President Prof. Matthias Willems provide insights into exciting developments in the field of digitization.
Read more
A research team from the University of Marburg has successfully used the cancer drug ruxolitinib to treat a 65-year-old female patient suffering from acute lung failure after coronavirus infection.
Read more
